Can-Fite BioPharma Files 6-K Report
Ticker: CANF · Form: 6-K · Filed: Mar 20, 2025 · CIK: 1536196
| Field | Detail |
|---|---|
| Company | Can-Fite Biopharma LTD. (CANF) |
| Form Type | 6-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, disclosure
TL;DR
Can-Fite BioPharma filed a 6-K on 3/20/25, updating its SEC filings.
AI Summary
On March 20, 2025, Can-Fite BioPharma Ltd. filed a Form 6-K, incorporating a press release by reference into its existing SEC registration statements. This filing relates to its ongoing operations as a foreign private issuer.
Why It Matters
This filing provides an update on Can-Fite BioPharma's regulatory status and incorporates information into its existing SEC filings, which is important for investors tracking the company's disclosures.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that incorporates previous information and does not appear to contain new material financial or operational news.
Key Players & Entities
- Can-Fite BioPharma Ltd. (company) — Filer of the 6-K report
- 26 Ben Gurion Street (location) — Company's principal executive office address
- Ramat Gan (location) — City of company's principal executive office
- Israel (location) — Country of company's principal executive office
- March 20, 2025 (date) — Date of the filing and the report
FAQ
What type of SEC filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer.
Who is the filer of this report?
The filer is Can-Fite BioPharma Ltd.
What is the filing date?
The filing date is March 20, 2025.
What is the company's principal executive office address?
The company's principal executive office is located at 26 Ben Gurion Street, Ramat Gan, 5257346, Israel.
What is being incorporated by reference into the registration statements?
The first paragraph of the press release attached as Exhibit 99.1 is being incorporated by reference.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 20, 2025 regarding Can-Fite BioPharma Ltd. (CANF).